Enterprise Value
$251.47 B
+$7.66 B+3.14%
Fri, 07 Feb 2025 00:59:26 GMT
Summary
- As of February 7, 2025, AZN enterprise value is $251.47 billion, with a rise of +$7.66 billion (+3.14%) during the most recent trading day.
- Over the past year, AZN enterprise value has increased by +$20.70 billion (+8.97%).
- AZN enterprise value is now -16.03% below its all-time high of $299.47 billion.
Performance
AZN Enterprise Value Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Enterprise Value Formula
Enterprise Value = Market Cap + Total Debt − Cash & Cash Equivalents
AZN Enterprise Value Trends
| PeriodPeriod | Enterprise valueEnterprise value | Market capMarket cap | PricePrice |
|---|---|---|---|
| todaytoday | +3.1% | +3.5% | +3.5% |
| 1 m1 month | +5.8% | +6.6% | +6.6% |
| 3 m3 months | +11.7% | +13.3% | +13.3% |
| 6 m6 months | -7.7% | -8.6% | -8.6% |
| ytdytd | +9.3% | +10.6% | +10.6% |
| 1 y1 year | +9.0% | +8.0% | +8.0% |
| 5 y5 years | +74.4% | +71.1% | +44.9% |
AZN Enterprise Value Highs & Lows
| PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
|---|---|---|---|---|---|
| 1 m | 1-month | at high | $230 B | +9.3% | |
| 3 m | 3-month | $251 B | at high | $223 B | +12.6% |
| 6 m | 6-month | $299 B | -16.0% | $223 B | +12.6% |
| 1 y | 1-year | $299 B | -16.0% | $212 B | +18.4% |
| 3 y | 3-year | $299 B | -16.0% | $189 B | +33.0% |
| 5 y | 5-year | $299 B | -16.0% | $112 B | +124.5% |
| alltime | all time | $299 B | -16.0% | $11 B | +2269.7% |
AstraZeneca Enterprise Value History
| Date | Value |
|---|---|
| 2025 | $251.47 B(+9.3%) |
| 2024 | $230.01 B(-1.0%) |
| 2023 | $232.30 B(-0.4%) |
| 2022 | $233.22 B(+13.8%) |
| 2021 | $204.96 B(+42.5%) |
| 2020 | $143.79 B(+0.1%) |
| 2019 | $143.71 B(+29.9%) |
| 2018 | $110.61 B(+8.1%) |
| 2017 | $102.36 B(+26.3%) |
| 2016 | $81.01 B(-14.5%) |
| 2015 | $94.76 B(+1.3%) |
| 2014 | $93.50 B(+23.2%) |
| 2013 | $75.92 B(+22.8%) |
| 2012 | $61.85 B(-0.4%) |
| 2011 | $62.12 B(-2.3%) |
| 2010 | $63.61 B(-8.2%) |
| Date | Value |
|---|---|
| 2009 | $69.25 B(+23.1%) |
| 2008 | $56.25 B(-21.5%) |
| 2007 | $71.68 B(-5.9%) |
| 2006 | $76.15 B(+2.5%) |
| 2005 | $74.27 B(+23.7%) |
| 2004 | $60.04 B(-26.4%) |
| 2003 | $81.63 B(+35.1%) |
| 2002 | $60.43 B(-25.9%) |
| 2001 | $81.58 B(-10.1%) |
| 2000 | $90.77 B(+21.3%) |
| 1999 | $74.84 B(+84.2%) |
| 1998 | $40.63 B(+16.6%) |
| 1997 | $34.84 B(+27.5%) |
| 1996 | $27.32 B(+40.6%) |
| 1995 | $19.44 B(+46.4%) |
| 1994 | $13.28 B(+8.6%) |
| 1993 | $12.23 B |
FAQ
- What is AstraZeneca enterprise value?
- What is the all time high enterprise value for AstraZeneca?
- What is AZN enterprise value year-to-date change?
- What is AstraZeneca enterprise value year-on-year change?
What is AstraZeneca enterprise value?
The current enterprise value of AZN is $251.47 B
What is the all time high enterprise value for AstraZeneca?
AstraZeneca all-time high enterprise value is $299.47 B
What is AZN enterprise value year-to-date change?
AstraZeneca enterprise value has changed by +$21.46 B (+9.33%) since the beginning of the year
What is AstraZeneca enterprise value year-on-year change?
Over the past year, AZN enterprise value has changed by +$20.70 B (+8.97%)